Practical strategies for SARS-CoV-2 RT-PCR testing in resource-constrained settings

Standard SARS-CoV-2 testing relies on nasopharyngeal swabs processed via RT-qPCR. However, in many resource-limited settings, testing is hindered by shortages of trained personnel, protective gear, and reagents. Prior research has shown that nasopharyngeal sampling is the most reliable method for detecting the virus. Yet, it requires specialized equipment and trained individuals, which are not always available. This gap motivated researchers to explore alternative sampling methods that are easier to implement. The need for simpler, more accessible diagnostic tools has become increasingly urgent. Existing studies have not fully evaluated nasal swabs or sample stabilization techniques in such settings. This uncertainty drove the investigation into nasal swab collection and RNA preservation methods. The goal was to determine if these alternatives could maintain diagnostic accuracy while reducing logistical barriers.

The study aimed to assess the feasibility of nasal swab collection for SARS-CoV-2 detection in resource-constrained settings. Researchers focused on comparing nasal swabs to the standard nasopharyngeal swabs. The specific problem addressed was the lack of testing capacity due to limited resources. The motivation was to find a method that could be self-administered and require fewer materials. The researchers also wanted to evaluate the impact of sample stabilization on viral load measurements. They tested two types of nasal swabs: flocked and 3D-printed. Additionally, they examined whether pooling samples could reduce resource use without sacrificing accuracy. The goal was to expand testing access while maintaining diagnostic reliability.

The study involved 275 participants and used nasal mid-turbinate swabs collected using either flocked or 3D-printed plastic lattice swabs. Swabs were placed into either viral transport media or an RNA stabilization agent. The collected samples were then tested using RT-qPCR for SARS-CoV-2 detection. The results were compared to those from nasopharyngeal swabs, which served as the reference standard. Researchers also evaluated the effect of sample pooling at the point of collection versus in the lab. Viral load measurements were analyzed to determine the impact of storage conditions and swab types. The study included both quantitative and qualitative assessments of diagnostic accuracy. The methods were designed to test the practicality of nasal swabs in low-resource environments.

Among the 275 participants, nasal flocked swabs identified 104 out of 121 PCR-positive cases detected by nasopharyngeal swabs, yielding a sensitivity of 87% (95% CI 79-92%). These swabs missed individuals with low viral loads, typically below 10^3 viral copies per microliter. 3D-printed nasal swabs showed similar diagnostic accuracy. When nasal swabs were placed in an RNA stabilizer, the mean decrease in viral copies per microliter compared to nasopharyngeal samples dropped from 1.4 log to less than 1 log. This improvement was observed even when samples were stored at room temperature for up to 7 days. Pooling specimens or swabs successfully detected viral loads above 10^2 copies per microliter. The results suggest that nasal swabs can be a viable alternative in resource-limited settings. The use of RNA stabilizers helped maintain diagnostic accuracy despite storage conditions.

The authors concluded that nasal swabs are likely adequate for clinical diagnosis of acute SARS-CoV-2 infections. These swabs can help expand testing capacity in resource-constrained settings. When collected into an RNA preservative that inactivates infectious virus, nasal swabs yielded viral load measurements comparable to nasopharyngeal samples. The study supports the use of nasal swabs as a practical alternative when nasopharyngeal testing is not feasible. The findings suggest that nasal swabs can be self-administered and require fewer resources. The use of RNA stabilizers improved sample stability and diagnostic accuracy. Pooling samples at the point of collection or in the lab did not compromise detection of high viral loads. The results align with the goal of making diagnostic testing more accessible in low-resource environments.